127 related articles for article (PubMed ID: 7536091)
1. Use of prostate-specific antigen for prostate cancer screening in primary care practice.
Williams RB; Boles M; Johnson RE
Arch Fam Med; 1995 Apr; 4(4):311-5. PubMed ID: 7536091
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing use of the prostate-specific antigen screening test in primary care.
Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
4. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
[TBL] [Abstract][Full Text] [Related]
5. GP and patient predictors of PSA screening in Australian general practice.
Gattellari M; Young JM; Ward JE
Fam Pract; 2003 Jun; 20(3):294-303. PubMed ID: 12738699
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
8. Influence of publication of US and European prostate cancer screening trials on PSA testing practices.
Zeliadt SB; Hoffman RM; Etzioni R; Gore JL; Kessler LG; Lin DW
J Natl Cancer Inst; 2011 Mar; 103(6):520-3. PubMed ID: 21357307
[TBL] [Abstract][Full Text] [Related]
9. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians.
Austin OJ; Valente S; Hasse LA; Kues JR
Arch Fam Med; 1997; 6(5):453-8. PubMed ID: 9305688
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen screening in elderly men.
Lu-Yao G; Stukel TA; Yao SL
J Natl Cancer Inst; 2003 Dec; 95(23):1792-7. PubMed ID: 14652241
[TBL] [Abstract][Full Text] [Related]
11. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
Ross LE; Taylor YJ; Richardson LC; Howard DL
J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
[TBL] [Abstract][Full Text] [Related]
12. Attitudes and practices of primary care physicians for prostate cancer screening.
Hoffman RM; Papenfuss MR; Buller DB; Moon TE
Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
[TBL] [Abstract][Full Text] [Related]
13. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening--a physician survey in Missouri.
Lawson DA; Simoes EJ; Sharp D; Murayi T; Hagan R; Brownson RC; Wilkerson J
J Community Health; 1998 Oct; 23(5):347-58. PubMed ID: 9793832
[TBL] [Abstract][Full Text] [Related]
15. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.
Meigs JB; Barry MJ; Giovannucci E; Rimm EB; Stampfer MJ; Kawachi I
Am J Med; 1998 Jun; 104(6):517-25. PubMed ID: 9674713
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.
Morlando M; Pelullo CP; Di Giuseppe G
PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514
[TBL] [Abstract][Full Text] [Related]
17. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use?
Edlefsen KL; Mandelson MT; McIntosh MW; Andersen MR; Wagner EH; Urban N
Am J Prev Med; 1999 Jul; 17(1):87-90. PubMed ID: 10429758
[TBL] [Abstract][Full Text] [Related]
19. The impact of informed consent on patient interest in prostate-specific antigen screening.
Wolf AM; Nasser JF; Wolf AM; Schorling JB
Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843
[TBL] [Abstract][Full Text] [Related]
20. Predictors of prostate cancer screening among health fair participants.
Chiu BC; Anderson JR; Corbin D
Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
